Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON combination in NSCLC
NCT00271271Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin, vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started Jun 2003; status: completed.
02
Drugs
gemcitabineoxaliplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00271271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271271.